2018 annual financial data
ProQR Therapeutics 2018 Operating margin
ProQR Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was -734.53%.
Operating income was -36,293,000 EUR and net income was -36,894,000 EUR.
Operating cash flow was -30,682,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,941,000 EUR
- Operating income
- -36,293,000 EUR
- Net income
- -36,894,000 EUR
- Operating cash flow
- -30,682,000 EUR